{
  "subset": "indication",
  "disease": "Osteogenesis imperfecta",
  "relation": "indication",
  "gold_drugs": [
    "risedronate sodium",
    "setrusumab"
  ],
  "seeds_initial": [
    "Bisphosphonates",
    "Zoledronic acid",
    "Calcium",
    "Pamidronate",
    "Vitamin D",
    "Teriparatide",
    "Risedronate",
    "Strontium ranelate",
    "Alendronate",
    "Denosumab",
    "Calcitonin",
    "Growth hormone"
  ],
  "seed_history": [
    [
      "Bisphosphonates",
      "Zoledronic acid",
      "Calcium",
      "Pamidronate",
      "Vitamin D",
      "Teriparatide",
      "Risedronate",
      "Strontium ranelate",
      "Alendronate",
      "Denosumab",
      "Calcitonin",
      "Growth hormone"
    ],
    [
      "Bisphosphonates",
      "Teriparatide",
      "Denosumab",
      "Calcitonin",
      "Pamidronate",
      "Zoledronic acid",
      "Risedronate",
      "Alendronate",
      "Lanthanum carbonate",
      "Strontium ranelate",
      "Growth hormone",
      "Thyroid hormone"
    ]
  ],
  "final_report": {
    "final_recommendations": [
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_teriparatide",
          "name": "Teriparatide"
        },
        "score": 0.45,
        "graph_snapshot_ref": "GE_H2_round4",
        "key_assumptions": [
          "促进骨形成有助于减轻骨折风险",
          "副作用的监测需得到加强"
        ],
        "caveats": [
          "持续监测副作用风险仍是关键"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H6",
        "candidate": {
          "id": "drug_zoledronic_acid",
          "name": "Zoledronic acid"
        },
        "score": 0.43,
        "graph_snapshot_ref": "GE_H6_round4",
        "key_assumptions": [
          "适用于骨质疏松症的治疗",
          "需持续关注副作用"
        ],
        "caveats": [
          "副作用风险较高，使用需谨慎"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_bisphosphonates",
          "name": "Bisphosphonates"
        },
        "score": 0.42,
        "graph_snapshot_ref": "GE_H1_round4",
        "key_assumptions": [
          "能提高骨密度，是改善骨强度的潜在选择"
        ],
        "caveats": [
          "显著的副作用风险可能抵消效果"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H5",
        "candidate": {
          "id": "drug_pamidronate",
          "name": "Pamidronate"
        },
        "score": 0.42,
        "graph_snapshot_ref": "GE_H5_round4",
        "key_assumptions": [
          "作为双膦酸盐，有助于改善骨密度"
        ],
        "caveats": [
          "安全性仍需关注"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H8",
        "candidate": {
          "id": "drug_alendronate",
          "name": "Alendronate"
        },
        "score": 0.41,
        "graph_snapshot_ref": "GE_H8_round4",
        "key_assumptions": [
          "能够有效改善骨密度"
        ],
        "caveats": [
          "使用时需要考虑副作用"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_denosumab",
          "name": "Denosumab"
        },
        "score": 0.4,
        "graph_snapshot_ref": "GE_H3_round4",
        "key_assumptions": [
          "通过抑制骨吸收提高骨密度"
        ],
        "caveats": [
          "副作用风险需关注"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H7",
        "candidate": {
          "id": "drug_risedronate",
          "name": "Risedronate"
        },
        "score": 0.39,
        "graph_snapshot_ref": "GE_H7_round4",
        "key_assumptions": [
          "影响骨代谢，有助于改善骨密度"
        ],
        "caveats": [
          "副作用风险需考虑"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H4",
        "candidate": {
          "id": "drug_calcitonin",
          "name": "Calcitonin"
        },
        "score": 0.38,
        "graph_snapshot_ref": "GE_H4_round4",
        "key_assumptions": [
          "适用于调节骨代谢"
        ],
        "caveats": [
          "副作用风险需谨慎使用"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H10",
        "candidate": {
          "id": "drug_strontium_ranelate",
          "name": "Strontium ranelate"
        },
        "score": 0.3,
        "graph_snapshot_ref": "GE_H10_round4",
        "key_assumptions": [
          "改善骨质量的可能性"
        ],
        "caveats": [
          "副作用风险显著"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H11",
        "candidate": {
          "id": "drug_growth_hormone",
          "name": "Growth hormone"
        },
        "score": 0.28,
        "graph_snapshot_ref": "GE_H11_round4",
        "key_assumptions": [
          "有潜在益处但影响间接"
        ],
        "caveats": [
          "副作用需关注"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H12",
        "candidate": {
          "id": "drug_thyroid_hormone",
          "name": "Thyroid hormone"
        },
        "score": 0.26,
        "graph_snapshot_ref": "GE_H12_round4",
        "key_assumptions": [
          "影响骨代谢的潜在因素"
        ],
        "caveats": [
          "使用需谨慎"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H9",
        "candidate": {
          "id": "drug_lanthanum_carbonate",
          "name": "Lanthanum carbonate"
        },
        "score": 0.25,
        "graph_snapshot_ref": "GE_H9_round4",
        "key_assumptions": [
          "适应性不足"
        ],
        "caveats": [
          "缺乏对骨代谢的直接证据"
        ],
        "confidence": "low"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Bone Health Pathway → Osteogenesis Imperfecta",
          "reason": "影响疾病表型的关键通路"
        }
      ],
      "remaining_gaps": [
        "需补充各候选药物与目标之间的更详细作用机制证据"
      ]
    },
    "seed_retrospective": {
      "batches": [],
      "lessons": []
    },
    "prompt_patches": [],
    "heuristics": []
  },
  "experience_used": true,
  "explorer_prompt": "List drugs that could be indicated for the rare disease 'Osteogenesis imperfecta'. Return only names.\n\n# Heuristics:\n- When 骨密度与骨折风险相关设计临床试验: then 引入长期观察机制以评估药物的效益和风险"
}